-- The global needle-free injection systems market size reached USD 120.7 Million in 2021 and is expected to register a revenue CAGR of 17.5% during the forecast period, according to latest analysis by Emergen Research.
The market for needle-free injection systems is anticipated to expand dramatically over the next few years as demand for non-invasive drug delivery systems rises. These devices are an appealing option for both patients and medical professionals since they provide a painless and efficient substitute for conventional needle injections.
The rising incidence of chronic diseases, which has raised demand for drug delivery systems, is one of the key factors driving this market. Since they are less invasive and therefore easier to give in outpatient settings, needle-free injection devices are particularly helpful when giving vaccines and other drugs. Additionally, by lowering the anxiety and terror related to needle injections, these devices can increase patient compliance.
However, there are a number of obstacles that could prevent the market for needle-free injection devices from expanding. The high cost of these devices, which can prevent some patients and healthcare professionals from using them, is one of the main obstacles. In addition, the absence of regulatory guidelines and standards for these devices can raise questions regarding their efficacy and safety.
Click the link to get a Free Sample Copy of the Report: https://www.emergenresearch.com/request-sample/1796
Despite these obstacles, a number of things are anticipated to propel the market for needle-free injection systems in the years to come. One of these aspects is the rising amount of money spent on these systems' research and development, which is anticipated to result in the creation of more cutting-edge and efficient equipment. Additionally, it is anticipated that the increasing use of these systems in emerging economies will open up new potential for market players.
The World Health Organisation (WHO) reported that in 2020, more than 80% of the world's population has gotten at least one dose of vaccination by the age of one, underscoring the significance of vaccine administration. The need for needle-free injection systems is also being driven by the rising frequency of infectious diseases because these tools are more efficient than conventional needle injections at halting the transmission of infectious diseases.
According to Emergen Research's analysis on market segmentation, the needle-free injection systems market is anticipated to be dominated by the jet injectors segment over the next several years. This is because jet injectors, which are very efficient in delivering insulin and other medications, are in high demand in the healthcare industry. The report also points out that due to their significant investments in the development of novel drug delivery systems, the pharmaceutical and biotechnology firms segment is anticipated to account for the highest share of the market in terms of end users.
Needle free Injection Systems Market Segmentation:
The global needle-free injection systems market can be segmented based on product outlook, technology outlook, type outlook, application outlook, and end-use outlook.
Under product outlook, the market is divided into fillable needle-free injectors and prefilled needle-free injectors. The prefilled needle-free injectors segment accounted for a significant revenue share in 2021 due to its ease of use and convenience.
Based on technology outlook, the market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, and micro-array patch. The jet-based needle-free injectors segment accounted for the largest revenue share in 2021 due to their fast and efficient drug delivery.
The market can also be segmented based on type outlook, with liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors being the major sub-segments.
In terms of application outlook, the market can be divided into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and other applications. The vaccine delivery segment is expected to grow significantly due to the increasing demand for efficient and safe delivery of vaccines. Based on end-use outlook, the market is segmented into hospitals, home-care settings, research laboratories, and pharmaceutical & biotechnology companies. The hospital segment is expected to dominate the market due to the increasing prevalence of chronic diseases and the need for efficient drug delivery.
The report also provides a regional analysis of the market, with a focus on North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/needle-free-injection-systems-market
Some Key Highlights from the Report
Needle free Injection Systems Market - Prefilled needle-free injectors segment accounted for a significant revenue share in 2021 due convenience and ease of use, making them a preferred choice for patients and healthcare providers. These injectors come pre-filled with medication, eliminating the need for manual filling, which can reduce the risk of errors in medication dosage and administration.
Jet-based needle-free injectors segment accounted for largest revenue share in 2021 due to jet injectors offer a fast and efficient mode of drug delivery without the use of needles. They work by using a high-pressure stream of liquid to penetrate the skin and deliver the medication directly into the subcutaneous tissue or muscle. This method of delivery is faster than traditional needle-based injections and can improve patient compliance.
Market in APAC accounted for a moderate revenue share in 2021 Market growth in Asia-Pacific is supported by a number of factors due to one of the key drivers of growth in the APAC market increasing prevalence of chronic diseases such as diabetes and cancer. These conditions require regular medication administration, and needle-free injectors offer a less painful and more convenient option for patients, which is driving the demand for these systems in the region.
Some major companies in the global market report include PharmaJet, Portal Instruments, Medical International Technology Inc., NuGen Medical Devices, CrossJect, Halozyme, Inc., Zealand Pharma A/S, Enesi, IntegriMedical LLC, Akra Dermojet.
On August 23, 2021, PharmaJet, a developer of novel needle-free injection technology, announced that its partner, Zydus Cadila, had received emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for its COVID-19 vaccine, which is administered using PharmaJet's needle-free injection system.
Explore All of our Published Healthcare Titles@ https://www.emergenresearch.com/industry-details/healthcare-and-pharmaceuticals
About Us: Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Info:
Name: Eric Lee
Email: Send Email
Organization: Emergen Research
Address: 14671 110 Avenue, Surrey, British Columbia, V3R2A9
Phone: 604757975
Website: https://www.emergenresearch.com/
Release ID: 89094640
Google
RSS